SS Innovations International (NASDAQ: SSII) announced that its subsidiary, the SS International Centre for Robotics Surgery (SSICRS), has graduated the inaugural class of its Cardiac Robotic Surgery Training program. The five-day course brought together 33 participants from seven countries and 16 international faculty members for classroom instruction, live surgical demonstrations and hands-on training using the company’s SSi Mantra surgical robotic system.
According to the company, the training center combines modern lecture facilities, advanced simulation labs, tele-proctoring and online learning modules to support surgeon education and the broader adoption of robotic-assisted surgery. SS Innovations said SSICRS plans to expand its educational offerings through additional condensed training programs covering multiple surgical specialties, including urology, gynecology, thoracic, colorectal, gastrointestinal and general surgery. This expansion reflects the company’s commitment to making robotic surgery more accessible worldwide.
The SSi Mantra system, developed by SS Innovations, is designed to be a cost-effective and user-friendly alternative to existing robotic surgical platforms. The company’s product range also includes its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. As an American company headquartered in India, SS Innovations aims to expand the global presence of its technologically advanced solutions.
The graduation of this first class is significant because it demonstrates the company’s ability to train surgeons from diverse international backgrounds, potentially accelerating the adoption of robotic-assisted surgery in regions where access to such technology is limited. The program’s structure, which combines hands-on training with digital learning tools, could serve as a model for future surgical education initiatives.
For more details on the press release, visit https://ibn.fm/7oFgo. Information about SS Innovations and its forward-looking statements can be found on the InvestorBrandNetwork website at http://IBN.fm/Disclaimer.
